These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10077011)

  • 1. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents.
    Su MY; Wang Z; Carpenter PM; Lao X; Mühler A; Nalcioglu O
    J Magn Reson Imaging; 1999 Feb; 9(2):177-86. PubMed ID: 10077011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging.
    Daldrup-Link HE; Shames DM; Wendland M; Mühler A; Gossmann A; Rosenau W; Brasch RC
    Acad Radiol; 2000 Nov; 7(11):934-44. PubMed ID: 11089696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
    AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent.
    Raatschen HJ; Swain R; Shames DM; Fu Y; Boyd Z; Zierhut ML; Wendland MF; Misselwitz B; Weinmann HJ; Wolf KJ; Brasch RC
    Contrast Media Mol Imaging; 2006; 1(3):113-20. PubMed ID: 17193687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
    Pediatr Radiol; 1998 Feb; 28(2):67-78. PubMed ID: 9472047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade.
    Brasch RC; Daldrup H; Shames D; Wendland M; Okuhata Y; Rosenau W
    Acad Radiol; 1998 Apr; 5 Suppl 1():S2-5. PubMed ID: 9561030
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
    Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
    J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of single- and dual-tracer pharmacokinetic modeling of dynamic contrast-enhanced MRI data using low, medium, and high molecular weight contrast agents.
    Orth RC; Bankson J; Price R; Jackson EF
    Magn Reson Med; 2007 Oct; 58(4):705-16. PubMed ID: 17899608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods.
    Helbich TH; Roberts TP; Gossmann A; Wendland MF; Shames DM; Adachi M; Yang S; Huber S; Daldrup H; Brasch RC
    Magn Reson Med; 2000 Dec; 44(6):915-24. PubMed ID: 11108629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
    Turetschek K; Huber S; Floyd E; Helbich T; Roberts TP; Shames DM; Tarlo KS; Wendland MF; Brasch RC
    Radiology; 2001 Feb; 218(2):562-9. PubMed ID: 11161179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights.
    Su MY; Mühler A; Lao X; Nalcioglu O
    Magn Reson Med; 1998 Feb; 39(2):259-69. PubMed ID: 9469709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
    Schnorr J; Wagner S; Ebert W; Heyer C; Laub G; Kivelitz D; Abramjuk C; Hamm B; Taupitz M
    Rofo; 2003 Jun; 175(6):822-9. PubMed ID: 12811696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
    Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
    Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
    Cohen FM; Kuwatsuru R; Shames DM; Neuder M; Mann JS; Vexler V; Rosenau W; Brasch RC
    Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic properties of Gd-DTPA-24-cascade-polymer--a new macromolecular MR contrast agent.
    Schwickert HC; Roberts TP; Mühler A; Stiskal M; Demsar F; Brasch RC
    Eur J Radiol; 1995 Jul; 20(2):144-50. PubMed ID: 7588870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.
    Boschi F; Marzola P; Sandri M; Nicolato E; Galiè M; Fiorini S; Merigo F; Lorusso V; Chaabane L; Sbarbati A
    MAGMA; 2008 May; 21(3):169-76. PubMed ID: 18317830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.
    Turetschek K; Floyd E; Helbich T; Roberts TP; Shames DM; Wendland MF; Carter WO; Brasch RC
    J Magn Reson Imaging; 2001 Sep; 14(3):237-42. PubMed ID: 11536400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model.
    Ostrowitzki S; Fick J; Roberts TP; Wendland MF; Aldape KD; Mann JS; Israel MA; Brasch RC
    J Magn Reson Imaging; 1998; 8(4):799-806. PubMed ID: 9702880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.
    Clemént O; Mühler A; Vexler VS; Kuwatsuru R; Berthezène Y; Rosenau W; Brasch RC
    J Magn Reson Imaging; 1993; 3(1):71-7. PubMed ID: 8428104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.